SCHEMBL196425

SCHEMBL196425

O=C(C=Cc1ccccc1)c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 8/20 1.00
MAOB P27338 12/20 0.86
MAPT P10636 4/20 0.75
TNFRSF1A P19438 2/20 0.75
PLIN1 O60240 1/20 0.75
LMNA P02545 1/20 0.75
BCHE P06276 1/20 0.75
ACHE P22303 1/20 0.75
RECQL P46063 1/20 0.75
PLIN5 Q00G26 1/20 0.75
ABHD5 Q8WTS1 1/20 0.75
CXCL12 P48061 1/20 0.72
MAOA P21397 4/20 0.71
MEN1 O00255 2/20 0.71
HSPD1 P10809 2/20 0.71
HSPE1 P61604 2/20 0.71
KMT2A Q03164 2/20 0.71
ALDH2 P05091 1/20 0.71
CYP3A4 P08684 1/20 0.71
CYP19A1 P11511 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196424 1.00 CYP1B1 (1.00) CYP1B1MAOBMAPTTNFRSF1APLIN1
SCHEMBL10415521 1.00 CYP1B1 (1.00) CYP1B1MAOBMAPTTNFRSF1APLIN1
4-Chloro Chalcone SCHEMBL198518 0.93 MAOB (1.00) CYP1B1MAOBMAPTTNFRSF1APLIN1
4-Chloro Chalcone SCHEMBL197311 0.93 MAOB (1.00) CYP1B1MAOBMAPTTNFRSF1APLIN1
4-Chloro Chalcone SCHEMBL197310 0.93 MAOB (1.00) CYP1B1MAOBMAPTTNFRSF1APLIN1
4',4-Dichlorochalcone SCHEMBL659210 0.90 MAOB (0.86) CYP1B1MAOBMAPTTNFRSF1ACXCL12
4',4-Dichlorochalcone SCHEMBL659211 0.90 MAOB (0.86) CYP1B1MAOBMAPTTNFRSF1ACXCL12
SCHEMBL2648476 0.90 MAOB (0.81) CYP1B1MAOBMAPTTNFRSF1APLIN1
SCHEMBL2664997 0.90 MAOB (0.81) CYP1B1MAOBMAPTTNFRSF1APLIN1
SCHEMBL657311 0.90 MAOB (0.81) CYP1B1MAOBMAPTTNFRSF1APLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117384199-A Preparation of novel organic aluminum hydrogen compound and preparation method of unsaturated alcohol compound catalyzed by novel organic aluminum hydrogen compound 北京理工大学 2024-01-12 CN claimed
US-9334253-B2 Direct trifluoromethylations using trifluoromethane UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2016-05-10 US claimed
US-20140066640-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-03-06 US claimed
WO-2012148772-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2012-11-01 WO claimed
EP-4567018-A1 METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2025-06-11 EP disclosed
CN-119630628-A Process for producing fluorinated organic compound 大金工业株式会社 2025-03-14 CN disclosed
US-20250051299-A1 PRODUCTION METHOD FOR FLUOROMETHYL DERIVATIVE DAIKIN INDUSTRIES, LTD. (JP) 2025-02-13 US disclosed
US-12162854-B2 Production method for fluoromethyl derivative DAIKIN INDUSTRIES, LTD. (JP) 2024-12-10 US disclosed
CN-114524829-B Preparation method of imidazo [2,1-b ] thiazole derivative 新疆大学 2024-04-02 CN disclosed
WO-2024029525-A1 METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND ダイキン工業株式会社 2024-02-08 WO disclosed
CN-117384199-A Preparation of novel organic aluminum hydrogen compound and preparation method of unsaturated alcohol compound catalyzed by novel organic aluminum hydrogen compound 北京理工大学 2024-01-12 CN disclosed
CN-116284114-A Method for synthesizing chiral 1, 3-phosphine alcohol 陕西师范大学 2023-06-23 CN disclosed
US-5308545-A Pyrazoline compounds CIBA-GEIGY CORPORATION (US) 1994-05-03 US disclosed
US-4904794-A Pyrazoline compounds CIBA-GEIGY CORPORATION (US) 1990-02-27 US disclosed
US-4816590-A Pyrazoline compounds and method of whitening CIBA-GEIGY CORPORATION (US) 1989-03-28 US disclosed
EP-0282448-A2 Pyrazoline compounds CIBA-GEIGY AG (CH) 1988-09-14 EP disclosed
EP-0236913-A2 Aryl-azolylmethyl-benzocyclo-alkene derivatives, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-16 EP disclosed
US-4439418-A UNSATURATED ARYL KETONE HENKEL KGAA (DE) 1984-03-27 US disclosed
EP-0004624-B1 CHROMANON DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICINES AND GROWTH-PROMOTING AGENTS BAYER AG (DE) 1982-02-24 EP disclosed
US-4261988-A ANTICHOLESTEROL AGENTS USED IN ANIMAL HUSBANDRY BAYER AKTIENGESELLSCHAFT (DE) 1981-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066640-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE TST, FLI1, CYP2F1 CYP1B1 1586/4885MAOB 2391/4885MAPT 3128/4885
US-12162854-B2 Production method for fluoromethyl derivative AFF1, AFF2, ROS1 CYP1B1 23/4885MAOB 20/4885MAPT 3085/4885
US-20250051299-A1 PRODUCTION METHOD FOR FLUOROMETHYL DERIVATIVE AFF1, AFF2, ROS1 CYP1B1 23/4885MAOB 20/4885MAPT 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.